During the past decade, Ross Eyecare conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ross Eyecare" #1 collaborator was "Foresight Regulatory Strategies, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ross Eyecare" are "Refractive Error - Myopia Bilateral" (2 trials) and "Refractive Errors" (1 trials). Many other conditions were trialed in "Ross Eyecare" in a lesser frequency.

Most popular intervention types in "Ross Eyecare" are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Hioxifilcon A standard hydrogel contact lens with Hyaluronic Acid (HA)" (2 trials), "Phase A - olifilcon B with Tangible Coatings" (1 trials) and "Phase B - etafilcon A with Tangible Coatings" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ross Eyecare" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ross Eyecare". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ross Eyecare, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ross Eyecare, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".